| NCT ID | NCT07779967 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Illinois at Urbana-Champaign |
| Condition | Alcohol Drinking |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-09-03 |
| Primary Completion | 2031-07-13 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2026-09-03 with a primary completion date of 2031-07-13.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Alcohol consumption, even at low levels, has been associated with increased breast cancer risk, but the biological mechanisms underlying this relationship remain unclear. This study will examine whether breast tissue may locally metabolize alcohol by measuring alcohol-related compounds in paired blood and breast milk samples from lactating women. The findings may help clarify alcohol-related biological pathways relevant to breast cancer risk and improve risk communication.
Eligibility Criteria
Inclusion Criteria: All aims -Drink alcohol (at least one alcoholic drink during lactation of a lactating female) For aims 1 and 2 * Nursing a 2- to 5-month-old infant * Experienced with a breast pump Exclusion Criteria: * Pregnant * Lifetime history of alcohol dependence * Drink more than 3 standard drinks per day or more than 7 standard drinks per week in the month previous to enrollment * Current regular use of drugs with addiction potential (other than alcohol) * Use of medications known to interact with alcohol metabolism * Current smoking * Anemia * Diabetes * Liver disease
Contact & Investigator
Marta Y Pepino de Gruev
PRINCIPAL INVESTIGATOR
University of Illinois at Urbana-Champaign
Frequently Asked Questions
Who can join the NCT07779967 clinical trial?
This trial is open to female participants only, aged 21 Years or older, up to 45 Years, studying Alcohol Drinking. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07779967 currently recruiting?
Yes, NCT07779967 is actively recruiting participants. Contact the research team at ypepino@illinois.edu for enrollment information.
Where is the NCT07779967 trial being conducted?
This trial is being conducted at Urbana, United States.
Who is sponsoring the NCT07779967 clinical trial?
NCT07779967 is sponsored by University of Illinois at Urbana-Champaign. The principal investigator is Marta Y Pepino de Gruev at University of Illinois at Urbana-Champaign. The trial plans to enroll 50 participants.